Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (17)
Yuxin Wang, Xueshuai Wan & Shunda Du. (2023) Integrated analysis revealing a novel stemness-metabolism-related gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma. Frontiers in Immunology 14.
Crossref
Crossref
Lorena Zara, Francesca Moraca, Jacqueline E. Van Muijlwijk-Koezen, Barbara Zarzycka, Robert Abel & Iwan J. P. de Esch. (2022) Exploring the Activity Profile of TbrPDEB1 and hPDE4 Inhibitors Using Free Energy Perturbation. ACS Medicinal Chemistry Letters 13:6, pages 904-910.
Crossref
Crossref
Maarten Ooms & Guy Bormans. 2021. PET and SPECT of Neurobiological Systems. PET and SPECT of Neurobiological Systems
851
877
.
Dechun Chen, Guanghui Hu, Shuai Zhang, Hongfu Zhang & Xiaohua Teng. (2020) Ammonia-triggered apoptosis via immune function and metabolic process in the thymuses of chickens by proteomics analysis. Ecotoxicology and Environmental Safety 198, pages 110619.
Crossref
Crossref
Hyelim Kim, Hoe Suk Kim & Woo Kyung Moon. (2019) Comparison of transcriptome expression alterations by chronic exposure to low-dose bisphenol A in different subtypes of breast cancer cells. Toxicology and Applied Pharmacology 385, pages 114814.
Crossref
Crossref
Dan Li & David J. Paterson. (2019) Pre-synaptic sympathetic calcium channels, cyclic nucleotide-coupled phosphodiesterases and cardiac excitability. Seminars in Cell & Developmental Biology 94, pages 20-27.
Crossref
Crossref
Ritawidya, Ludwig, Briel, Brust & Scheunemann. (2019) Synthesis and In Vitro Evaluation of 8-Pyridinyl-Substituted Benzo[e]imidazo[2,1-c][1,2,4]triazines as Phosphodiesterase 2A Inhibitors. Molecules 24:15, pages 2791.
Crossref
Crossref
Killian Oukoloff, Bobby Lucero, Karol R. Francisco, Kurt R. Brunden & Carlo Ballatore. (2019) 1,2,4-Triazolo[1,5-a]pyrimidines in drug design. European Journal of Medicinal Chemistry 165, pages 332-346.
Crossref
Crossref
Li Liu, Jing Zheng, Xian-Feng Huang, Xia Zhu, Shu-Ming Ding, Heng-Ming Ke, James M. O'Donnell, Han-Ting Zhang, Guo-Qiang Song & Ying Xu. (2018) The neuroprotective and antidepressant-like effects of Hcyb1, a novel selective PDE2 inhibitor. CNS Neuroscience & Therapeutics 24:7, pages 652-660.
Crossref
Crossref
Susann Schröder, Barbara Wenzel, Winnie Deuther-Conrad, Rodrigo Teodoro, Mathias Kranz, Matthias Scheunemann, Ute Egerland, Norbert Höfgen, Detlef Briel, Jörg Steinbach & Peter Brust. (2018) Investigation of an 18F-labelled Imidazopyridotriazine for Molecular Imaging of Cyclic Nucleotide Phosphodiesterase 2A. Molecules 23:3, pages 556.
Crossref
Crossref
Ashley B. Forster, Pravien Abeywickrema, Jaime Bunda, Christopher D. Cox, Tamara D. Cabalu, Melissa Egbertson, John Fay, Krista Getty, Dawn Hall, Maria Kornienko, Jun Lu, Gopal Parthasarathy, John Reid, Sujata Sharma, William D. Shipe, Sean M. Smith, Stephen Soisson, Shawn J. Stachel, Hua-Poo Su, Deping Wang & Richard Berger. (2017) The identification of a novel lead class for phosphodiesterase 2 inhibition by fragment-based drug design. Bioorganic & Medicinal Chemistry Letters 27:23, pages 5167-5171.
Crossref
Crossref
Max Lam, Joey W. Trampush, Jin Yu, Emma Knowles, Gail Davies, David C. Liewald, John M. Starr, Srdjan Djurovic, Ingrid Melle, Kjetil Sundet, Andrea Christoforou, Ivar Reinvang, Pamela DeRosse, Astri J. Lundervold, Vidar M. Steen, Thomas Espeseth, Katri Räikkönen, Elisabeth Widen, Aarno Palotie, Johan G. Eriksson, Ina Giegling, Bettina Konte, Panos Roussos, Stella Giakoumaki, Katherine E. Burdick, Antony Payton, William Ollier, Ornit Chiba-Falek, Deborah K. Attix, Anna C. Need, Elizabeth T. Cirulli, Aristotle N. Voineskos, Nikos C. Stefanis, Dimitrios Avramopoulos, Alex Hatzimanolis, Dan E. Arking, Nikolaos Smyrnis, Robert M. Bilder, Nelson A. Freimer, Tyrone D. Cannon, Edythe London, Russell A. Poldrack, Fred W. Sabb, Eliza Congdon, Emily Drabant Conley, Matthew A. Scult, Dwight Dickinson, Richard E. Straub, Gary Donohoe, Derek Morris, Aiden Corvin, Michael Gill, Ahmad R. Hariri, Daniel R. Weinberger, Neil Pendleton, Panos Bitsios, Dan Rujescu, Jari Lahti, Stephanie Le Hellard, Matthew C. Keller, Ole A. Andreassen, Ian J. Deary, David C. Glahn, Anil K. Malhotra & Todd Lencz. (2017) Large-Scale Cognitive GWAS Meta-Analysis Reveals Tissue-Specific Neural Expression and Potential Nootropic Drug Targets. Cell Reports 21:9, pages 2597-2613.
Crossref
Crossref
Satoshi Mikami, Shinji Nakamura, Tomoko Ashizawa, Izumi Nomura, Masanori Kawasaki, Shigekazu Sasaki, Hideyuki Oki, Hironori Kokubo, Isaac D. Hoffman, Hua Zou, Noriko Uchiyama, Kosuke Nakashima, Naomi Kamiguchi, Haruka Imada, Noriko Suzuki, Hiroki Iwashita & Takahiko Taniguchi. (2017)
Discovery of Clinical Candidate
N
-((1
S
)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl)-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-
b
]pyrazine-4(1
H
)-carboxamide (TAK-915): A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders
. Journal of Medicinal Chemistry 60:18, pages 7677-7702.
Crossref
Crossref
Stefania Monterisi, Miguel J Lobo, Craig Livie, John C Castle, Michael Weinberger, George Baillie, Nicoletta C Surdo, Nshunge Musheshe, Alessandra Stangherlin, Eyal Gottlieb, Rory Maizels, Mario Bortolozzi, Massimo Micaroni & Manuela Zaccolo. (2017) PDE2A2 regulates mitochondria morphology and apoptotic cell death via local modulation of cAMP/PKA signalling. eLife 6.
Crossref
Crossref
Laurent Gomez, Mark Eben Massari, Troy Vickers, Graeme Freestone, William Vernier, Kiev Ly, Rui Xu, Margaret McCarrick, Tami Marrone, Markus Metz, Yingzhou G. Yan, Zachary W. Yoder, Robert Lemus, Nicola J. Broadbent, Richard Barido, Noelle Warren, Kara Schmelzer, David Neul, Dong Lee, Carsten B. Andersen, Kristen Sebring, Kathleen Aertgeerts, Xianbo Zhou, Ali Tabatabaei, Marco Peters & J. Guy Breitenbucher. (2017) Design and Synthesis of Novel and Selective Phosphodiesterase 2 (PDE2a) Inhibitors for the Treatment of Memory Disorders. Journal of Medicinal Chemistry 60:5, pages 2037-2051.
Crossref
Crossref
Ligia Mendes Soares, Erika Meyer, Humberto Milani, Harry W. M. Steinbusch, Jos Prickaerts & Rúbia M. Weffort Oliveira. (2016)
The phosphodiesterase type 2 inhibitor
BAY
60‐7550 reverses functional impairments induced by brain ischemia by decreasing hippocampal neurodegeneration and enhancing hippocampal neuronal plasticity
. European Journal of Neuroscience 45:4, pages 510-520.
Crossref
Crossref
Satoshi Mikami, Masanori Kawasaki, Shuhei Ikeda, Nobuyuki Negoro, Shinji Nakamura, Izumi Nomura, Tomoko Ashizawa, Hironori Kokubo, Isaac Dylan HoffmanHua ZouHideyuki Oki, Noriko Uchiyama, Yuuto Hiura, Maki Miyamoto, Yuuki Itou, Masato Nakashima, Hiroki Iwashita & Takahiko Taniguchi. (2017) Discovery of a Novel Series of Pyrazolo[1,5-<i>a</i>]pyrimidine-Based Phosphodiesterase 2A Inhibitors Structurally Different from <i>N</i>-((1<i>S</i>)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl)-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-<i>b</i>]pyrazine-4(1<i>H</i>)-carboxamide (TAK-915), for the Treatment of Cognitive Disorders. CHEMICAL & PHARMACEUTICAL BULLETIN Chemical and Pharmaceutical Bulletin 65:11, pages 1058-1077.
Crossref
Crossref